HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ruo-Chia Tseng Selected Research

Neoplasms (Cancer)

7/2021Changes in SLIT2 expression are associated with the migration of human ovarian clear cell carcinoma cells.
12/2015Growth-arrest-specific 7C protein inhibits tumor metastasis via the N-WASP/FAK/F-actin and hnRNP U/β-TrCP/β-catenin pathways in lung cancer.
1/2015Deregulation of SLIT2-mediated Cdc42 activity is associated with esophageal cancer metastasis and poor prognosis.
9/2014HBP1 promoter methylation augments the oncogenic β-catenin to correlate with prognosis in NSCLC.
8/2009Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients.
3/2009Frequent down-regulation of hRAB37 in metastatic tumor by genetic and epigenetic mechanisms in lung cancer.
3/2008Minimal deletion regions in lung squamous cell carcinoma: association with abnormality of the DNA double-strand break repair genes and their applications on gene identification and prognostic biomarkers.
3/2003Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples.
4/2002Alterations of the p16(ink4a) gene in resected nonsmall cell lung tumors and exfoliated cells within sputum.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ruo-Chia Tseng Research Topics

Disease

9Neoplasms (Cancer)
07/2021 - 04/2002
6Lung Neoplasms (Lung Cancer)
11/2019 - 04/2002
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2014 - 07/2004
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2009 - 07/2004
2Carcinogenesis
11/2019 - 04/2002
2Neoplasm Metastasis (Metastasis)
12/2015 - 03/2009
2Breast Neoplasms (Breast Cancer)
01/2010 - 08/2009
2Adenocarcinoma of Lung
08/2009 - 02/2007
2Adenocarcinoma
07/2004 - 04/2002
1Chronic Kidney Failure (Chronic Renal Failure)
09/2013
1Genomic Instability
03/2008

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
07/2021 - 04/2002
5Messenger RNA (mRNA)IBA
11/2019 - 03/2003
3CateninsIBA
11/2019 - 09/2014
3DNA (Deoxyribonucleic Acid)IBA
09/2013 - 04/2002
2Biomarkers (Surrogate Marker)IBA
12/2015 - 03/2008
21,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
07/2009 - 03/2008
1LigandsIBA
07/2021
1Actins (F Actin)IBA
12/2015
1Heterogeneous-Nuclear Ribonucleoprotein UIBA
12/2015
1Slit homolog 2 proteinIBA
01/2015
1ImmunosorbentsIBA
09/2013
1EnzymesIBA
09/2013
1AntibodiesIBA
09/2013
1beta CateninIBA
01/2010
1Glycoproteins (Glycoprotein)IBA
01/2010
1Glycogen Synthase Kinase 3 betaIBA
01/2010
1Cadherins (E-Cadherin)IBA
01/2010
1Glycogen Synthase KinasesIBA
01/2010
1beta-Transducin Repeat-Containing ProteinsIBA
01/2010
1Sirtuin 1IBA
08/2009
1Monomeric GTP-Binding ProteinsIBA
03/2009
1Ku AutoantigenIBA
02/2007
1GuanineIBA
07/2004
1CytosineIBA
07/2004
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
07/2004
1Cyclin-Dependent Kinase Inhibitor p16IBA
04/2002

Therapy/Procedure

1Kidney Transplantation
09/2013
1Precision Medicine
01/2010